Cipla Collaborated with KARWA Ltd. for Marketing of ‘ELIFast’

Cipla on 28th October informed the public about the commercialization of IgG ELISA. It is an antibody detection tool to keep a check on Covid-19. It is launched under the name ‘ELIFast’.

The technology is transferred by ICMR (Indian Council of Medical Research) to KARWA Ltd. Cipla has collaborated with Karwa for this project.